Lupin Ltd. (LUPIN) Share Price Near 52-Week Low as Stock Trades at Rs 1,937
- October 8, 2026
- Posted by: Chaitanya Auti
- Category: News
Lupin Share Price is trading at Rs 1,937, down 0.86% from the previous close of Rs 1,953.75. The stock is near its 52-week low zone, and Lupin Share Price today is drawing attention because the market cap stands at Rs 89,343.03 crore. At 21 October 2026 at 12:22 PM IST, the latest Univest data confirms the price event, but it does not establish a company-specific catalyst. That makes Lupin Stock News relevant for investors tracking whether the current share price action reflects temporary selling pressure or a broader re-rating in the Indian stock market.
Lupin Share Price today moved between Rs 1,929.6 and Rs 1,959.3 after opening at Rs 1,950. The share price is below the previous close, and the near 52-week low setup keeps Lupin Share Price in focus for stock analysis, technical analysis and fundamental analysis. In this update, Univest tracks Lupin Share Price with a neutral lens: what happened, what the numbers say, and what investors should monitor next without turning the move into a prediction.
Lupin Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,937 |
| Previous Close | Rs 1,953.75 |
| Today's Move | Rs -16.75 (-0.86%) |
| Open | Rs 1,950 |
| High | Rs 1,959.3 |
| Low | Rs 1,929.6 |
| Market Capitalisation | Rs 89,343.03 crore |
Lupin Ltd. (LUPIN) traded at Rs 1,937 versus the previous close of Rs 1,953.75, a fall of 0.86%. The stock opened at Rs 1,950, reached a high of Rs 1,959.3, touched a low of Rs 1,929.6.
Lupin Share Price Today shows a modest intraday decline, with the stock last trading at Rs 1,937 versus the previous close of Rs 1,953.75. The move of Rs 16.75 lower, or 0.86%, places Lupin Share Price close to its 52-week low zone, which is why the name is appearing in stocks in news and 52 week low stocks screens. The day open at Rs 1,950, high of Rs 1,959.3 and low of Rs 1,929.6 show a narrow trading band, while the market cap of Rs 89,343.03 crore keeps Lupin in the large-cap healthcare bracket.
From a price action perspective, Lupin Share Price today is not showing sharp momentum, but it is also not collapsing in a disorderly way. The stock is trading just above the low of the day, so market participants are watching whether support holds around the one-year low area. For readers following Lupin Stock News and Lupin Share Price Live updates, the main question is whether selling pressure remains contained or extends further into the support level area.
Lupin Ltd. (LUPIN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 89,343.03 crore |
| P/E Ratio | 16.16x |
| P/B Ratio | 3.75x |
| ROE | 27.11% |
| ROCE | 28.86% |
| EPS | Rs 120.9 |
| Book Value Per Share | Rs 520.48 |
| Dividend Yield | 0.92% |
Lupin Ltd. (LUPIN) fundamental metrics show P/E 16.16x, P/B 3.75x, ROE 27.11%, ROCE 28.86%. These figures provide context only and are not a buy or sell signal.
Lupin Ltd. has a market capitalisation of Rs 89,343.03 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 16.16x, P/B at 3.75x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.11% and ROCE of 28.86%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 120.9, book value per share of Rs 520.48, dividend yield of 0.92%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.98x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 16.16x |
| Benchmark Median P/E | 26.98x |
| Benchmark Average P/E | 39.4x |
| Benchmark P/E Range | 0x to 616.89x |
| Company P/B Ratio | 3.75x |
| Benchmark Median P/B | 2.74x |
| Company ROE | 27.11% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 28.86% |
| Benchmark Median ROCE | 13.17% |
| Company Market Capitalisation | Rs 89,343.03 crore |
| Benchmark Median Market Cap | Rs 768.75 crore |
Lupin Ltd. (LUPIN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Lupin Ltd. (LUPIN) has a P/E ratio of 16.16x, which is below the benchmark median of 26.98x, a difference of -40.1%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Lupin Ltd. (LUPIN) has a ROE of 27.11%, which is above the benchmark median of 11.23%, a difference of +141.41%. Lupin Ltd. (LUPIN) has a ROCE of 28.86%, which is above the benchmark median of 13.17%, a difference of +119.13%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd. | AUROPHARMA | 92,923.53 | 25.03 | 2.39 | 9.93 | 12.76 |
| Mankind Pharma Ltd. | MANKIND | 93,013.62 | 45.54 | 5.53 | 12.69 | 13.24 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 1,03,667.29 | 32.17 | 2.72 | 11.69 | 13.75 |
| Cipla Ltd. | CIPLA | 1,07,527.58 | 31.9 | 3.06 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,022.18 | 24.6 | 4.12 | 19.69 | 21.39 |
Lupin Ltd. (LUPIN) has a P/E ratio of 16.16x compared with the displayed peer median of 31.9x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.11% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 28.86% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Lupin Ltd. (LUPIN) has a market capitalisation of Rs 89,343.03 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Lupin
- Lupin Share Price is trading near the 52-week low zone, which keeps price action in focus.
- The stock is down 0.86% today, with Lupin Share Price Today staying below the previous close.
- P/E of 16.16 is below the same-industry median, so valuation is a key part of Lupin Stock Analysis.
- ROE of 27.11% and ROCE of 28.86% remain strong in the healthcare sector context.
- The market cap of Rs 89,343.03 crore keeps Lupin among the large listed pharma names.
About Lupin
About Lupin, the company is a major listed pharmaceutical business in India operating in the Healthcare sector and the Pharmaceuticals & Drugs industry. Its business is anchored in medicines and related pharmaceutical offerings, which places it in a competitive category that investors often track through Lupin Share Price, Lupin Stock News and Lupin Financial Results.
The company’s latest quarter revenue of Rs 8,276.89 crore gives a scale reference for operating performance. The latest earnings profile also shows EPS of 120.9 and book value per share of 520.48, both useful for understanding the share price against the business base. With dividend yield at 0.92, Lupin Share Price continues to be evaluated mainly through earnings quality, valuation multiples and return ratios rather than income alone. For readers comparing Lupin NSE and Lupin BSE trading, the company remains a meaningful healthcare benchmark.
Track Lupin Share Price on Univest
Use Lupin Ltd. (LUPIN) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Univest can help investors track Lupin Share Price today with live price updates, technical indicators, fundamental ratios, shareholding pattern, 52-week levels and market insights. The platform also brings Lupin Share Price Update, Lupin Company News and Lupin Stock Analysis into one place for faster reading. For investors who monitor stocks in news and sector moves, Univest makes it easier to follow Lupin Share Price, valuation context and market positioning without losing the broader picture.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Lupin Share Price near a 52-week low?
Ans. Lupin Share Price is near its 52-week low because it is trading at Rs 1,937, below the previous close of Rs 1,953.75. The latest Univest data confirms the price event but does not establish a company-specific catalyst.
What is Lupin Share Price today?
Ans. Lupin Share Price today is Rs 1,937, which is Rs 16.75 lower than the previous close. The stock is trading near the yearly low zone, making it a key name in Lupin Stock News and share market tracking.
How much is Lupin Share Price down today?
Ans. Lupin Share Price is down 0.86% today. The stock opened at Rs 1,950, touched a high of Rs 1,959.3 and a low of Rs 1,929.6, showing a narrow intraday range around the low zone.
What does Lupin Share Price say about valuation?
Ans. Lupin Share Price is supported by a P/E of 16.16, which is below the industry median of 26.98. However, the P/B of 3.75 is above the median, so valuation looks mixed rather than uniformly cheap.
Is Lupin profitable based on its fundamentals?
Ans. Lupin’s fundamentals show strong return ratios. ROE is 27.11 and ROCE is 28.86, both well above the industry median. EPS of 120.9 and book value of 520.48 also add context for Lupin Share Price.
How does Lupin compare with pharma peers?
Ans. Lupin Share Price sits below many peers on P/E, including Cipla, Dr. Reddy’s and Mankind Pharma. Its ROE and ROCE are stronger than several listed peers, which makes the valuation and profitability mix notable.
What is Lupin’s market capitalisation?
Ans. Lupin has a market capitalisation of Rs 89,343.03 crore. That places Lupin Share Price in the large-cap healthcare category and well above the median market cap in the same-industry benchmark universe.
What do EPS and book value mean for Lupin Share Price?
Ans. EPS of 120.9 shows earnings per share, while book value of 520.48 shows the accounting net worth per share. These metrics help investors judge Lupin Share Price against profitability and balance-sheet support.
Does Lupin pay a dividend?
Ans. Lupin’s dividend yield is 0.92. That figure reflects current historical payout context, not a guaranteed future dividend, and it adds another layer to Lupin Share Price analysis alongside earnings and valuation.
What should investors track next in Lupin Stock News?
Ans. Investors should track whether Lupin Share Price holds near the low zone, how it trades versus its 50 DMA of 2,055.96 and 200 DMA of 2,248.13, and whether valuation remains supported by strong returns.